Results 301 to 310 of about 782,530 (393)

Patient‐Reported Dysphagia and Swallowing‐Related Quality of Life up to 10 Years After (Chemo)radiotherapy for Head and Neck Cancer: A Cross‐Sectional Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background This study sought to better understand patient‐reported dysphagia and swallowing‐related quality of life (swQOL) in patients 6 months to 10 years following definitive (chemo)radiotherapy for head and neck cancer (HNC). Methods In this cross‐sectional study, self‐reported dysphagia was assessed with the Eating Assessment Tool (EAT‐10)
Jacqui J. Frowen   +4 more
wiley   +1 more source

Assessment of Gastroesophageal Reflux Disease in Patients Exhibiting Otolaryngology Symptoms at a Tertiary Care Hospital. [PDF]

open access: yesCureus
Almasoudi T   +8 more
europepmc   +1 more source

Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross‐Species Multi‐Cohort Bioinformatic Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background The loss of the Y chromosome (LOY) and the extreme down‐regulation of Y chromosome gene expression (EDY) are frequently observed in oral squamous cell carcinoma (OSCC). However, their roles in oral potentially malignant disorders (OPMDs) are unclear.
Rui Han   +6 more
wiley   +1 more source

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Purpose Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy with limited therapeutic options in the recurrent/metastatic setting; little is known regarding its responsiveness to immunotherapy. Inhibition of enhancer of zeste homolog 2 (EZH2) has been shown to improve T‐cell‐mediated killing and susceptibility to immune checkpoint ...
Elisabetta Xue   +12 more
wiley   +1 more source

Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen   +6 more
wiley   +1 more source

Microbial incidence in acute pharyngitis using throat swab analysis

open access: gold
Mumtaz Ahmad Umar   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy